THE HEMODYNAMIC EFFECTS OF DIASPIRIN CROSS-LINKED HEMOGLOBIN IN DOPAMINE-RESISTANT ENDOTOXIC SHOCK IN SWINE ^*

REFERENCES

• Parker M. M., Shelhamer J. H., Natanson C., Alling D. W., Parrillo J. E. Serial cardiovascular variables in survivors and non-survivors of human septic shock. Crit. Care Med. 1987; 15: 923–929
   PubMed Web of Science ®Google Scholar
• Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993; 329: 2002–2012
   PubMed Web of Science ®Google Scholar
• Schultz S. C., Grady B., Cole F., Hamilton I., Burhop K., Malcolm D. S. A role for endothelin and nitric oxide in the pressor response to Diaspirin Cross-linked Hemoglobin. J. Lab. Clin. Med. 1993; 122: 301–308
   PubMed Web of Science ®Google Scholar
• Kilbourn R. G., Joly G., Cashon B., DeAngelo J., Bonaventura J. Cell-free hemoglobin reverses the endotoxin-mediated hyporesponsivity of rat aortic rings to alpha-adrenergic agents. Biochem. Biophys. Res. Commun. 1994; 199: 155–162
   PubMed Web of Science ®Google Scholar
• Sielenkamper A., Martin C. M., White M., d'Almeida M., Sibbald W. J., Chin-Yee I. Efficacy of Diaspirin Cross-linked Hemoglobin, fresh blood and old blood transfusion in O 2 supply-dependent septic rats. Artif. Cells Blood Substitutes, Immobilization Biotechnol. 1996; 24: 426
   Google Scholar
• Conhaim R. L., Rodenkirch L. A., Harms B. A. DCLHb flows through compressed lung capillaries that exclude red cells. Artif. Cells Blood Substitutes, Immobilization Biotechnol. 1996; 24: 323
   Google Scholar
• Jesmok G., Gundel R. Thromoxane-blocked swine as an experimental model of severe intravascular inflammation and septic shock. Shock 1995; 4: 379–383
   PubMed Web of Science ®Google Scholar
• Herbertson M. J., Werner H. A., Studer W., Russell J. A., Walley K. R. Decreased left ventricular contractility during porcine endotoxemia is not prevented by ibuprofen. Crit. Care Med. 1996; 24: 815–819
   Google Scholar
• Ogura H., Offner P. J., Saitoh D., Jordan B. S., Johnson A. A., Pruitt B. A., Jr., Cioffi W. G., Jr. The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model. Arch. Surg. 1994; 129: 1233–1239
   Google Scholar
• Ogura H., Cioffi W. G., Offner P. J., Jordan B. S., Johnson A. A., Pruitt B. A., Jr. Effect of inhaled nitric oxide on pulmonary function after SEP in a swine model. Surgery 1994; 116: 313–321
   Google Scholar
• Weitzberg E., Rudehill A., Modin A., Lundberg J. M. Effect of combined nitric oxide inhalation and N G-nitro-L-arginine infusion in porcine endotoxin shock. Crit. Care Med. 1995; 23: 909–918
   Google Scholar
• Nava E., Palmer R.M. J., Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?. Lancet 1991; 338: 1555–1557
   PubMed Web of Science ®Google Scholar
• Petros A., Bennett D., Valance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557–1558
   PubMed Web of Science ®Google Scholar
• Herbertson M. J., Werner H. A., Walley K. R. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am. J. Phys. 1996; 270: H1979–H1984
   Google Scholar
• Roth R. I., Kaca W., Levin J. Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Prog. Clin. Biol. Res. 1994; 388: 161–172
   PubMedGoogle Scholar
• Su D., Roth R. I., Yoshida M., Levin J. Hemoglobin increases mortality from bacterial endotoxin. Inf. Imm. 1997; 65: 1258–1266
   Google Scholar
• Vinten-Johansen J., Sato H., Zhao Z. Q. The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemic-reperfusion injury. Int. J. Cardiol. 1995; 50: 273–281
   PubMed Web of Science ®Google Scholar
• Yang B. C., Chen L. Y., Saldeen T. G., Mehta J. L. Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxide. Br. J. Pharmacol. 1997; 120: 301–311
   Google Scholar
• Brandtzaeg P., Osnes L., Ovstebo R., Joo G. B., Westvik A. B., Kierulf P. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of Interleukin-10 as a major functional deactivator of human monocytes. J. Exp. Med. 1996; 184: 51–60
   PubMed Web of Science ®Google Scholar
• Gardlund B., Sjolin J., Nilsson A., Roll M., Wickerts C. J., Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J. Infect. Dis. 1995; 172: 296–301
   PubMed Web of Science ®Google Scholar
• Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 88: 373–376
   Google Scholar
• Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 27: 524–526
   Google Scholar
• Ignarro L. J., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 1987; 84: 9265–9269
   PubMed Web of Science ®Google Scholar
• Vallance P., Palmer R. M., Moncada S. The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxemic rabbits. Br. J. Pharmacol. 1992; 106: 459–463
   Google Scholar
• Jia L., Bonaventura C., Bonaventura J., Stamler J. S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221–226
   PubMed Web of Science ®Google Scholar
• Geroulanos S., Schilling J., Cakmakci M., Jung H. H., Largiader F. Inhibition of nitric oxide synthesis in septic shock. Lancet 1992; 339: 435
   Google Scholar
• Lorente J. A., Landin L., De Pablo R., Renes E., Liste D. L-arginine pathway in the SEP syndrome. Crit. Care Med. 1993; 21: 1287–1295
   PubMed Web of Science ®Google Scholar
• Robertson F. M., Offner P. J., Ciceri D. P., Becker W. K., Pruitt B. A., Jr. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch. Surg. 1994; 129: 149–155
   PubMedGoogle Scholar
• Booke M., Hinder F., Traber L. D., McGuire R., Traber D. L. S-ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vasodilation in sheep. Shock 1995; 4: 274–281
   Google Scholar
• Hinder F., Booke M., Traber L. D., Matsumoto N., Nishida K., Rogers S., Traber D. L. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit. Care Med. 1996; 24: 131–136
   Google Scholar
• Strand O. A., Leone A. M., Giercksky K. E., Skovlund E., Kirkeboen K. A. N G-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis. Crit. Care Med. 1998; 26: 1490–1499
   Google Scholar
• Wright C. E., Rees D. D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 1992; 26: 48–57
   PubMed Web of Science ®Google Scholar
• Aranow J. S., Wang H., Zhuang J., Fink M. P. Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock. Crit. Care Med. 1996; 24: 807–814
   PubMed Web of Science ®Google Scholar
• Bone H. G., Schenarts P. J., Booke M., McGuire R., Harper D., Traber L. D., Traber D. L. Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep. Crit. Care Med. 1997; 25: 1010–1018
   PubMed Web of Science ®Google Scholar
• Thompson A., McGarry A. E., Valeri C. R., Lieberthal W. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J. Appl. Physiol. 1994; 77: 2348–2354
   PubMed Web of Science ®Google Scholar
• Mourelatos M. G., Enzer N., Ferguson J. L., Rypins E. B., Burhop K. E., Law W. R. The effects of Diaspirin Cross-linked Hemoglobin in sepsis. Shock 1996; 5: 141–148
   PubMed Web of Science ®Google Scholar
• Krishnamurti C., Carter A. J., Maglasang P., Hess J. R., Cutting M. A., Alving B. M. Cardiovascular toxicity of human cross-linked hemoglobin in a rabbit endotoxemia model. Crit. Care Med. 1997; 25: 1874–1880
   PubMedGoogle Scholar
• Reah G., Bodenham A., Mallick A., Daily E. K., Przybelski R. J. Initial evaluation of Diaspirin Cross-linked Hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit. Care Med. 1997; 25: 1480–1488
   PubMed Web of Science ®Google Scholar
• Rioux F., Petitclerc E., Audet R., Drapeau G., Fielding R. M., Marceau F. Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings. J. Cardiovasc. Pharmacol. 1994; 24: 229–237
   PubMedGoogle Scholar
• Ochoa J. B., Udekwu A. O., Billiar T. R., Curran R. D., Cerra F. B., Simmons R. L., Peitzman A. B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991; 214: 621–626
   PubMed Web of Science ®Google Scholar
• Shoemaker W. C., Appel P. L., Kram H. B. Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: dobutamine and dopamine effects. Crit. Care Med. 1991; 19: 672–688
   Google Scholar
• Yu M., Levy M. M., Smith P., Takiguchi S. A., Miyasaki A., Myers S. A. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit. Care Med. 1993; 21: 830–838
   PubMed Web of Science ®Google Scholar
• Powell R. J., Machiedo G. W., Rush B. F., Jr. Decreased red blood cell deformability and impaired oxygen utilization during human sepsis. Am. Surg. 1993; 59: 65–68
   Google Scholar
• Schultz S. C., Powell C. C., Bernard E., Malcolm D. S. Diaspirin Cross-linked Hemoglobin (DCLHb) attnuates bacterial translocation in rats. Artif. Cells Blood Substitutes, Immobilization Biotechnol. 1995; 23: 647–664
   PubMed Web of Science ®Google Scholar
• Crowley J. P., Metzger J., Gray A., Pivacek L. E., Cassidy G., Valeri C. R. Infusion of stroma-free cross-linked hemoglobin during acute gram-negative bacteremia. Circ. Shock 1993; 41: 144–149
   Google Scholar
• Sloan E. P., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M. N., Rodman G., Jr. Diaspirin Cross-linked Hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock—a randomized controlled efficacy trial. J. Am. Med. Assoc. 1999; 282: 1857–1864
   PubMed Web of Science ®Google Scholar